Journal of Bone Oncology

Papers
(The H4-Index of Journal of Bone Oncology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Bone metastases in thyroid cancer51
Separation surgery for metastatic epidural spinal cord compression: A qualitative review39
Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice37
Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis36
New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma36
Exosomes derived from bone marrow mesenchymal stem cells promote osteosarcoma development by activating oncogenic autophagy35
Epidemiology of spinal metastases, metastatic epidural spinal cord compression and pathologic vertebral compression fractures in patients with solid tumors: A systematic review33
Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer27
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group24
Targeting ferroptosis in osteosarcoma24
Baicalin induces apoptosis and autophagy in human osteosarcoma cells by increasing ROS to inhibit PI3K/Akt/mTOR, ERK1/2 and β-catenin signaling pathways22
Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis22
Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature21
Malignancy in giant cell tumor of bone in the extremities21
The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer20
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval20
The HMGB1/RAGE axis induces bone pain associated with colonization of 4T1 mouse breast cancer in bone20
Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma18
0.021314859390259